Joint Study definition

Joint Study. A teacher will be granted temporary leave to work on a committee jointly sponsored by the Board and the Association.
View Source
Joint Study means a clinical study that each Party will use to support any Regulatory Filings or activity in such Party’s portion of the Territory and for which the Parties have agreed to conduct and share costs pursuant to the Clinical Development Plan.
View Source
Joint Study means the activities of combining CNODC's and MIP's effort to reach the objective as described in Article 2.
View Source

Examples of Joint Study in a sentence

  • No later than sixty (60) days after execution and ratification of this Agreement, the Joint Study Committee shall establish a retrenchment retraining subcommittee which shall study and report on the feasibility of providing retraining opportunities for retrenched unit members.

  • Payroll deductions for membership dues of the Association or voluntary contributions to VOTE pursuant to the process agreed to by the Joint Study Committee shall be authorized pursuant to applicable laws of the Commonwealth.

  • The evaluation shall also include the evaluation by each unit member within the work area/program, the results of which shall be recorded on a form (See Department Chair Evaluation Forms XX–1 or XX–2 in Form Supplements); provided, however, that any changes made on the form by the Employer shall be preceded by consultation with the Joint Study Committee.

  • Joint Study Committees may be formed when deemed necessary by agreement of the teams to this agreement for one year only unless agreed upon by both teams.

  • Recommendations and reports of Joint Study Committees are advisory in nature.

  • If meetings of Joint Study Committees are scheduled during the regular school day, members of such committees shall be granted professional leave, without loss of pay or benefits.

  • Joint Study Committee reports are due by May 1 or as specified by the negotiation teams.

  • Upon completion of its study and submittal of a written report on the subject assigned to it, a Joint Study Committee shall be considered dissolved, and once dissolved, no such committee shall be reactivated except by consent of the Association and the Board.

  • The Joint Study Committee may use consultants if deemed necessary by either party.

  • FTNTT Faculty members may request that the matter be considered by the established Faculty Advisory Committee (Faculty Council in instances involving faculty assigned to a regional campus) and/or the FTNTT AAUP/KSU Joint Study Committee which body shall offer its advice on the matter in dispute to the unit administrator.

Related to Joint Study

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Pivotal Study means (a) a Phase 3 Study that is intended by Celgene to be submitted (together with any other registration trials that are prospectively planned when such Phase 3 Study is initiated) for Regulatory Approval in the U.S. or the EU, or (b) any other clinical study that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which clinical study is a registration trial intended to be sufficient for filing an application for a Regulatory Approval for the Licensed Product in the U.S. or another country or some or all of an extra-national territory, solely as evidenced by the acceptance for filing for a Regulatory Approval for such product after completion of such study.